abstract |
The present invention relates to quinazolinone compounds that are useful for treating cellular proliferative diseases, for treating disorders associated with KSP kinesin activity, and for inhibiting KSP kinesin. The invention als o related to compositions which comprise these compounds, and methods of using them to treat cancer in mammals. |